Winchell, Harry S.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Winchell, Harry S..The latest application filed is for "complexes of cyclic polyaza chelators with cations of alkaline earth metals for enhanced biological activity".

Company Profile

0.13.4

Winchell, Harry S. - Lafayette CA
Winchell; Harry S - Lafayette CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Complexes of cyclic polyaza chelators with cations of alkaline earth metals for enhanced biological activity App 20050112066 - Winchell, Harry S.	2005-05-26
Neuroprotection and cardioprotection afforded by chelators with high affinity and specificity for cations of first transition series elements Grant 6,881,732 - Winchell April 19, 2	2005-04-19
Neuroprotection and cardioprotection afforded by chelators with high affinity and specificity for cations of first transition series elements App 20040006055 - Winchell, Harry S.	2004-01-08
Compounds with chelation affinity and selectivity for first transition series elements: use in medical therapy and diagnosis Grant 6,583,182 - Winchell , et al. June 24, 2	2003-06-24
Processes for synthesis of cyclic and linear polyamine chelators containing N-monosubstituted coordinating arms App 20020091253 - Winchell, Harry S. ; et al.	2002-07-11
Compounds With Chelation Affinity And Selectivity For First Transition Series Elements And Their Use In Cosmetics And Personal Care Products, Inhibition Of Metalloenzymes, And Inhibition Of Reperfusion Injury Grant 6,387,891 - Winchell , et al. May 14, 2	2002-05-14
Compounds with chelation affinity and selectivity for first transition series elements and their use in cosmetics and personal care products, inhibition of metalloenzymes, and inhibition of reperfusion injury App 20010041170 - Winchell, Harry S. ; et al.	2001-11-15
Compounds with chelation affinity and selectivity for first transition series elements: use in medical therapy Grant 5,874,573 - Winchell , et al. February 23, 1	1999-02-23
MRI image enhancement of bone and related tissue using complexes of paramagnetic cations and polyphosphonate ligands Grant 5,236,695 - Winchell , et al. August 17, 1	1993-08-17
Stable diagnostic reagents Grant 4,364,920 - Winchell December 21, 1	1982-12-21
Amines useful as brain imaging agents Grant 4,360,511 - Baldwin , et al. November 23, 1	1982-11-23
Amides useful as brain imaging agents Grant 4,279,887 - Baldwin , et al. July 21, 1	1981-07-21
Radiographic compositions Grant 4,176,173 - Winchell , et al. November 27, 1	1979-11-27
Method of preparing X-ray contrast media containing ores of hafnium, tantalum and tungsten Grant 4,079,124 - Winchell March 14, 1	1978-03-14
99M-technetium labeled macroaggregated human serum albumin pharmaceutical Grant 4,024,233 - Winchell , et al. May 17, 1	1977-05-17
Hepato-biliary radiopharmaceutical comprising 2-mercaptoisobutyric acid chelating reduced technetium-99m Grant 3,928,552 - Winchell , et al. December 23, 1	1975-12-23
Technetium labeled tin colloid radiopharmaceuticals Grant 3,875,299 - Winchell , et al. April 1, 1	1975-04-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.